All Drug
Common Medicines
Oncology
Hematology
Hepatology
Chronic Diseases
Department of Endocrinology
Orphan drugs
Tumor area
Drug selection
Medical Information
-
Juxtapid contraindicated population: Notice for moderate to severe liver disease, pregnant and lactating patients
Lomitapide, as an MTP inhibitor, ha...
2026-06-18 16:21:56 -
Lometate side effect management: how to deal with nausea, bloating, and elevated transaminase levels
During treatment with Lometapine, s...
2026-06-18 16:19:50 -
Precautions for taking Lometapine: hepatotoxicity, fat diarrhea, and fat soluble vitamin deficiency
Lometapai is an MTP inhibitor used ...
2026-06-18 16:18:24 -
Juxtapid: Treatment of homozygous familial hypercholesterolemia with ATP inhibitors
Lomitapide is a microsomal triglyce...
2026-06-18 16:16:09 -
Side effect management of Liriopide tablets: how to deal with fever, diarrhea, and vomiting
If side effects such as fever, diar...
2026-06-17 17:54:50 -
Evrysdi contraindicated population: severe liver dysfunction, pregnant patients should be aware of
Evrysdi (Risperidone tablets) has c...
2026-06-17 17:53:06 -
Precautions for taking Risperidone tablets: hepatotoxicity, rash, and drug interactions
As an SMN2 splicing modifier, speci...
2026-06-17 17:51:45 -
Evrysdi (Risperidone Tablets): SMN2 Splicing Modifier Treatment Guidelines for SMA
Evrysdi (Risperidone tablets) is an...
2026-06-17 17:49:56